4-CHLORO-7-TOSYL-7H-PYRROLO[2,3-D]PYRIMIDINE CAS#: 479633-63-1; ChemWhat Code: 771333
Identification
| Product Name | 4-CHLORO-7-TOSYL-7H-PYRROLO[2,3-D]PYRIMIDINE CAS#: 479633-63-1 |
| IUPAC Name | 4-chloro-7-(4-methylphenyl)sulfonylpyrrolo[2,3-d]pyrimidine |
| Molecular Structure | ![]() |
| CAS Registry Number | 479633-63-1 |
| EINECS Number | No data available |
| MDL Number | MFCD09907939 |
| Beilstein Registry Number | No data available |
| Synonyms | 4-chloro-7-tosyl-7H-pyrrolo[2,3-d]pyrimidine4-chloro-7-(p-toluenesulfonyl)pyrrolo[2,3-d]pyrimidine4-chloro-7-[(4-methylphenyl)sulfonyl]-7H-pyrrolo[2,3-d]pyrimidine4-chloro-7-(p-toluenesulfonyl)-7H-pyrrolo[2,3-d]pyrimidine4-chloro-7-tosyl-pyrrolo[2,3-d]pyrimidine4-chloro-7-(p-tolylsulfonyl)pyrrolo[2,3-d]pyrimidine |
| Molecular Formula | C13H10ClN3O2S |
| Molecular Weight | 307.755 |
| InChI | InChI=1S/C13H10ClN3O2S/c1-9-2-4-10(5-3-9)20(18,19)17-7-6-11-12(14)15-8-16-13(11)17/h2-8H,1H3 |
| InChI Key | BTOJSYRZQZOMOK-UHFFFAOYSA-N |
| Canonical SMILES | Cc1ccc(cc1)S(=O)(=O)n2ccc3c2ncnc3Cl |
| Patent Information | ||
| Patent ID | Title | Publication Date |
| US2019/308972 | PREPARATION METHOD FOR AND INTERMEDIATE OF PYRROLO SIX-MEMBERED HETEROAROMATIC RING DERIVATIVE | 2019 |
| TW2018/37039 | PREPARATION METHOD FOR PYRROLE SIX-MEMBERED HETEROARYL RING DERIVATIVE AND INTERMEDIATE THEREOF | 2018 |
| CN106946917 | New synthesis methods of JCK inhibitor baricitinib and intermediate thereof | 2017 |
Physical Data
| Appearance | Off white to white solid |
| Solubility | No data available |
| Flash Point | No data available |
| Refractive index | No data available |
| Sensitivity | No data available |
| Melting Point, °C |
| 147 – 149 |
| 140.2 – 147.7 |
| Measurement Temperature, °C | Type (Density) | Comment (Density) |
| 22.84 | crystallographic | Density: 1.519 g/cm3 |
Spectra
| Description (NMR Spectroscopy) | Nucleus (NMR Spectroscopy) | Solvents (NMR Spectroscopy) | Original Text (NMR Spectroscopy) |
| Chemical shifts | 1H | chloroform-d1 | ‘H NMR (400 MHz, CDCh) 8: 8.76 (s, 1H), 8.08 (d, 2H), 7.77 (d, 1H), 4.32 (d, 2H), 6.70 (d, 1H), 2.40 (s, 3H). |
| Chemical shifts, Spectrum | 13C | dichloromethane-d2 | |
| Chemical shifts | 1H | Chemical shifts | 1H NMR (DMSO-d6, 400 MHz) δ 8.78 (s, 1H), 8.10 (d, 2H), 7.79 (d, 1H), 7.34 (d, 2H), 6.72 (d, 1H), 2.41 (s, 3H) ppm; |
| Description (Mass Spectrometry) |
| liquid chromatography mass spectrometry (LCMS), electron impact (EI), spectrum |
| electrospray ionisation (ESI), spectrum |
| high resolution mass spectrometry (HRMS), IT (ion trap), spectrum |
| liquid chromatography mass spectrometry (LCMS), electron impact (EI), spectrum |
Route of Synthesis (ROS)
| Conditions | Yield |
| With potassium carbonate In lithium hydroxide monohydrate at 100℃; for 16h; | 90% |
| With potassium carbonate In tetrahydrofuran; lithium hydroxide monohydrate at 20℃; Reflux; | 85.5% |
| With potassium carbonate In tetrahydrofuran; lithium hydroxide monohydrate at 20℃; Reflux; | 85.5% |
| With potassium carbonate In lithium hydroxide monohydrate for 16h; Reflux; Inert atmosphere; | 1.24g |
| With potassium carbonate In tetrahydrofuran at 70 – 80℃; Large scale; | 70kg |
Safety and Hazards
| Pictogram(s) | ![]() |
| Signal | Warning |
| GHS Hazard Statements | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation] Information may vary between notifications depending on impurities, additives, and other factors. |
| Precautionary Statement Codes | P264, P264+P265, P280, P302+P352, P305+P351+P338, P321, P332+P317, P337+P317, and P362+P364 (The corresponding statement to each P-code can be found at the GHS Classification page.) |
Other Data
| Transportation | NONH for all modes of transport |
| Under the room temperature and away from light | |
| HS Code | No data available |
| Storage | Under the room temperature and away from light |
| Shelf Life | 2 years |
| Market Price | USD |
| Druglikeness | |
| Lipinski rules component | |
| Molecular Weight | 94.116 |
| logP | -0.047 |
| HBA | 2 |
| HBD | 1 |
| Matching Lipinski Rules | 4 |
| Veber rules component | |
| Polar Surface Area (PSA) | 38.91 |
| Rotatable Bond (RotB) | 0 |
| Matching Veber Rules | 2 |
| Use Pattern |
| Commonly used as an intermediate of tofacitinib. |
Buy Reagent | |
| No reagent supplier? | Send quick inquiry to ChemWhat |
| Want to be listed here as a reagent supplier? (Paid service) | Click here to contact ChemWhat |
Approved Manufacturers | |
| Want to be listed as an approved manufacturer (Requires approvement)? | Please download and fill out this form and send back to approved-manufacturers@chemwhat.com |
Other Suppliers | |
| Watson International Limited | Visit Watson Official Website |
Contact Us for Other Help | |
| Contact us for other information or services | Click here to contact ChemWhat |



![HNMR of 4-Chloro-7-tosyl-7H-pyrrolo[2,3-d]pyrimidine CAS 479633-63-1](https://www.chemwhat.com/wp-content/uploads/2018/03/HNMR-of-4-Chloro-7-tosyl-7H-pyrrolo23-dpyrimidine-CAS-479633-63-1.png)
![Route of Synthesis (ROS) of 4-CHLORO-7-TOSYL-7H-PYRROLO[2,3-D]PYRIMIDINE CAS# 479633-63-1](https://www.chemwhat.com/wp-content/uploads/2018/03/Route-of-Synthesis-ROS-of-4-CHLORO-7-TOSYL-7H-PYRROLO23-DPYRIMIDINE-CAS-479633-63-1.png)
